Virological efficacy and safety of antiretroviral therapy-switch to atazanavir-based regimen: a review of the literature.

about

Switching antiretroviral regimes for the treatment of HIV: safety implications.

P2860

Q38879406-6D4FED79-AE1F-481D-93B2-C4E00470C3A1

P2860

Virological efficacy and safety of antiretroviral therapy-switch to atazanavir-based regimen: a review of the literature.

Item

http://www.wikidata.org/entity/Q38050815

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Virological efficacy and safet ...... n: a review of the literature.

@en

type

Item

label

Virological efficacy and safet ...... n: a review of the literature.

@en

prefLabel

Virological efficacy and safet ...... n: a review of the literature.

@en

P1476

Virological efficacy and safet ...... n: a review of the literature.

@en

P2093

Christoph Stephan

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Telaprevir for previously untreated chronic hepatitis C virus infection

Boceprevir for untreated chronic HCV genotype 1 infection

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.

Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study

P304

2355-2367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2012.734296

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23050508

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

virology

Virological efficacy and safety of antiretroviral therapy-switch to atazanavir-based regimen: a review of the literature.

about

P2860

P2860

Virological efficacy and safety of antiretroviral therapy-switch to atazanavir-based regimen: a review of the literature.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921